2021-2022 Regular Session • Massachusetts Legislature
H2071: Relative to opioid drug manufacturer assessments
Legislative Summary
For legislation to establish an opioid treatment and addiction prevention fund. Mental Health, Substance Use and Recovery.
Bill History
3/29/2021
Referred to the Joint Committee on Mental Health, Substance Use and Recovery
House of Representatives
3/29/2021
Senate concurred
Senate
9/8/2021
Hearing scheduled for 10/04/2021 from 01:00 PM-05:00 PM in Virtual Hearing
Joint Conference
2/9/2022
Reporting date extended to Monday May 9, 2022, pending concurrence
House of Representatives
3/24/2022
Senate concurred
Senate
5/12/2022
Reporting date extended to Tuesday May 31, 2022, pending concurrence
House of Representatives
5/26/2022
Senate concurred
Senate
6/2/2022
Reporting date extended to Thursday June 2, 2022, pending concurrence
House of Representatives
6/2/2022
Senate concurred
Senate
9/6/2022
Accompanied a study order, see H5194
House of Representatives
Status Information
Current Status
Introduced(3/29/2021)
Chamber
House of Representatives
Sponsors
Democrat: 3
Republican: 1
Primary Sponsor
Claire Cronin
Democrat